Clinical Trial Update: Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD [Phase 1, Phase 2]

View source ↗

Summary

AERO-007 Inhalation Solution from AeroRx Therapeutics, a nebulized LABA/LAMA combination, completed a Phase 1/Phase 2a trial for maintenance treatment of chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AERO-007 Inhalation Solution

Snippet

Sponsor: AeroRx Therapeutics Inc. | Conditions: COPD | Phase 1, Phase 2 | Status: COMPLETED